A detailed history of Atala Financial Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Atala Financial Inc holds 2,090 shares of JNJ stock, worth $323,950. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,090
Previous 2,440 14.34%
Holding current value
$323,950
Previous $353 Million 1.78%
% of portfolio
0.25%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025

SELL
$142.06 - $167.7 $49,721 - $58,694
-350 Reduced 14.34%
2,090 $347 Million
Q4 2024

Feb 10, 2025

BUY
$143.34 - $165.86 $349,749 - $404,698
2,440 New
2,440 $353 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Atala Financial Inc Portfolio

Follow Atala Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atala Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atala Financial Inc with notifications on news.